P

Palmetto Clinical Trial Services, LLC. | Anderson Location

Research site

(Unclaimed)

Location

1411 North Main Street, Anderson, South Carolina, United States of America

Site insights

Top conditions

Top treatments

Ruxolitinib

IMG-007

Tulisokibart

Difamilast

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 7 total trials

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis (ADAPTIVE)

The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.

Enrolling

Atopic Dermatitis

Atopic Dermatitis Eczema

Drug: Placebo

Drug: IMG-007

Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)

This is a phase 2b randomized, double-blind, placebo-controlled study of the safety and efficacy of tulisokibart in participants with moderate to sev...

Enrolling

Hidradenitis Suppurativa

Drug: Placebo

Drug: Tulisokibart

Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense (TibuSHIELD)

The study is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to evaluate the effects of tibulizumab over 16 weeks (Period...

Enrolling

Hidradenitis Suppurativa (HS)

Biological: Tibulizumab Dose B

Other: Placebo